Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):

Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):

Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):

Abstract: 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol is prepared from the novel intermediate, 6-ethyl-4?-(1-ethyl-1-hydroxypropyl)-2?-propylbiphenyl-3-ol.

Abstract: A novel method for preparing 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid includes a Suzuki reaction between 3-adamantyl-4-methoxyphenylboronic acid of formula (II): and 6-bromo-2-naphthoic acid of formula (III):

Abstract: A novel method for preparing 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid includes a Suzuki reaction between 3-adamantyl-4-methoxyphenylboronic acid of formula (II): and 6-bromo-2-naphthoic acid of formula (III):

Abstract: Novel 7,7-disubstituted (5H,9H)-6,8-dioxabenzocycloheptene compounds having the structural formula (I): are useful intermediates in the synthesis of non-steroidal derivatives of vitamin D.

Abstract: 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol is prepared from the novel intermediate, 6-ethyl-4?-(1-ethyl-1-hydroxypropyl)-2?-propylbiphenyl-3-ol

Abstract: The invention relates to novel diaminopyrazole having formula (I), wherein: R1, R2, identical or different, represent a C3 C5 mono- or polyhydroxyalkyl, isopropyl, n-propyl or ethyl group, said groups being linear or branched, and their physiologically acceptable salts. The invention also relates to a composition for dyeing keratinous fibres containing a compound having formula (I) and the method for using same.

Abstract: Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR? receptor, such biaromatic ligand having the structural formula (I): and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.

Abstract: The invention relates to novel diaminopyrazole compounds having formula (I): wherein R1 represents a linear or branched C4-C5 alkyl or n-propyl group, or a linear or branched C3-C5 mono or polyhydroxy alkyl group, and the addition salts thereof with a physiologically acceptable acid. The invention also relates to the compositions containing such a compound for the dyeing of keratinous fibres and the method for using said compositions.

Abstract: The invention concerns novel diaminopyrazole derivatives of formula (I), wherein: R1 represents C1-C6 alkyl or C2-C6, preferably up to C4, alkenyl, linear or branched, bearing at least a substituent selected among OR, NHR, NRR?, SR, SO2R, COOH, CONH2, CONRR?, PO(OH)2, SH, SO3X, a non-cationic heterocycle, Cl, Br or I?; X represents H, Na, K or NH4; R and R?, identical or different, represent C1-C6 alkyl or C2-C6, preferably up to C4, alkenyl, linear or branched, unsubstituted or substituted by one or several functional groups selected among OH, NH2, OR, NHR, NRR?, SR, SOR, SO2R, COOH, CONH2, CONRR?, PO(OH)2, SH, SO3X, a non-cationic heterocycle, Cl, Br or I, X, R and R? having the definitions mentioned above; R2 represents H, or C1-C6 alkyl or C2-C6, preferably up to C4, alkenyl, linear or branched, unsubstituted or substituted by one or several functional groups selected among OH, NH2, OR, NHR, NRR?, SR, SOR, SO2R, COOH, CONH2, CONRR?, PO(OH)2, SH, SO3X, a non-cationic heterocycle, Cl, Br or I, X, R and R? h

Abstract: The subject of the invention is a composition for the oxidation dyeing of keratinous fibers, in particular human hair, comprising an oxidation base of the para-phenylenediamine type, substituted with a diazacycloheptane radical. The invention also relates to the method for dyeing fibers using this composition, and the novel compounds of the type mentioned above.

Abstract: Novel 7,7-disubstituted (5H,9H)-6,8-dioxabenzocycloheptene compounds having the structural formula (I): are useful intermediates in the synthesis of non-steroidal derivatives of vitamin D.

Abstract: Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR? receptor, such biaromatic ligand having the structural formula (I): and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.

Abstract: The invention concerns novel dyeing compositions for keratinous fibers comprising at least a paraphenylenediamine derivative with pyrrolidinyl group as oxidation base, a dyeing method and a dyeing kit using said composition.

Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):

Abstract: Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR? receptor, such biaromatic ligand having the structural formula (I): and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.

Abstract: The invention relates to diaminopyrazole derivatives having the following structure (I), wherein R1 represents an alkyl or alkenyl radical bearing at least one substituent selected from among OR, NRR?, SR, SOR, SO2R, COOR, CONRR?, PO(OH)2, SO3X, NHCONRR, a non-cationic heterocycle, an aryl, a halogen. R2 and R3 are different from H and represent, independently of each other, an alkyl or alkenyl group; R2 and R3, together with the nitrogen atom to which they are attached, can form a heterocycle possibly comprising at least one other heteroatom selected from among N, O and S; R2 and R3 or the heterocycle that they form with the nitrogen to which they are attached can be substituted by at least one substituent defined above.

Abstract: The invention concerns compounds derived from diaminopyrazole of formula (I), wherein: Ar is a 5- or 6-membered heteroaromatic radical capable of being condensed with one or several heteroaromatic cycles each comprising 5 or 6 members, and their physiologically acceptable addition salts with and acid.